-
2023-509259-15-01
Phase IV
1 country
-
2024-512192-12-00
Phase III/IV
1 country
PREDNISOLONE
-
2024-512884-30-00
Phase III
2 countries
PERTUZUMAB
-
2024-515820-35-02
Phase IV
1 country
PREGABALIN
-
2024-517149-15-00
Phase IV
1 country
CAPECITABINE; OXALIPLATIN
-
2024-518793-14-00
Phase IV
1 country
CEFALEXIN MONOHYDRATE; FLUCONAZOLE
-
2024-518794-33-00
Phase IV
1 country
BLEOMYCIN SULFATE PH. EUR.
-
2024-519738-21-01
Phase IV
1 country
FERRIC CARBOXYMALTOSE; SODIUM CHLORIDE
-
2024-519876-17-00
Phase IV
1 country
-
2024-520083-33-00
Phase IV
1 country
TAFLUPROST
-
2024-520291-10-01
Phase IV
1 country
-
2025-524769-26-00
Phase II
1 country
ZONGERTINIB
-
2026-526142-27-01
Phase III
1 country
SODIUM CHLORIDE; TRANEXAMIC ACID
-
2025-521179-29-00
Phase II/III
2 countries
-
2024-518817-24-01
Phase IV
1 country
-
2024-515958-24-00
Phase III
1 country
CEFUROXIME, CEFUROXIME; CIPROFLOXACIN; ERTAPENEM
-
2024-517676-37-01
Phase I (Other)
1 country
-
2024-514857-31-00
Phase II
1 country
HUMAN PLASMA PROTEIN; MAGNESIUM CHLORIDE HEXAHYDRATE, POTASSIUM CHLORIDE, SODIUM…
-
2024-520288-15-00
Phase IV
1 country
CAPECITABINE; FLUOROURACIL
-
2024-512475-12-01
Phase IV
1 country
ENOXAPARIN SODIUM; TINZAPARIN SODIUM
-
2024-517478-68-01
Phase II
1 country
ABEMACICLIB; ALECTINIB; APALUTAMIDE; ASCIMINIB HYDROCHLORIDE; ATEZOLIZUMAB; BEXM…
-
2024-517508-12-00
Phase IV
1 country
-
2023-508147-43-00
Phase IV
1 country
-
2024-518312-40-00
Phase I (Other)
1 country